Session IV
PDAC / Translational science

Programme

• 15:15 – 15:45 20 Min. 10 Min.

  • Invited lecture

  Therapy of PDAC – past, present and future

  • Prof. Dr. John Neoptolemos (Heidelberg / DE)
• 15:45 – 15:55 8 Min. 2 Min.

  • Oral presentation
  • O29

  A response prediction platform for personalized antitumor therapy in pancreatic cancer

  • Johannes Hulkkonen (Heidelberg / DE)

   Pancreatic cancer
• 15:55 – 16:05 8 Min. 2 Min.

  • Oral presentation
  • O30

  Establishment of a drug screening platform based on tumor fragments

  • Maurice Sagorsky (Düsseldorf / DE)

   Pancreatic cancer
• 16:05 – 16:15 8 Min. 2 Min.

  • Oral presentation
  • O31

  Spatial biology helps to identify CAR target candidates against pancreatic adenocarcinoma

  • Dr. Daniel Schäfer (Bergisch Gladbach / DE)

   Pancreatic cancer
• 16:15 – 16:25 8 Min. 2 Min.

  • Oral presentation
  • O32

  Tumor response grading as a potential prognostic marker in neoadjuvant treated pancreatic carcinoma

  • Dr. Anna-Katharina König (Heidelberg / DE)

   Pancreatic cancer
• 16:25 – 16:35 8 Min. 2 Min.

  • Oral presentation
  • O33

  Integration of biological characteristics of pancreatic cancer PDX and CDX models with clinical annotations of the donor patients

  • Marie Knak (Göttingen / DE)

   Pancreatic cancer
• 16:35 – 16:45 8 Min. 2 Min.

  • Oral presentation
  • O34

  p62/SQSTM1 remodels biophysical fingerprints in metastatic pancreatic cancer

  • Dr. Kıvanç Görgülü (München / DE)

   Pancreatic cancer